Related Experiment Videos
Decision support in trauma management: predicting potential cases of Ventilator Associated Pneumonia
1Trauma Research Department, Swedish Medical Center, Englewood, CO, USA. adrianp@bezeqint.net
Abstract:
Ventilator Associated Pneumonia (VAP) is a complication of intubated trauma patients and a leading cause in Intensive Care Unit (ICU) mortality. Since early diagnosis, by specimen culture takes days to complete, an overuse of broad spectrum antibiotics is the usual treatment. As a result there is the risk of developing antibiotic resistant strains. Using an Artificial Neural Network (ANN) derived model to predict those at risk would result in reduced risk of resistant strains, a lowering of mortality rates and considerable savings in treatment costs. Artificial Neural Networks work well on classification problems, using feed-forward/back propagation methodology. Using the National Trauma Data Bank (V6.2) data files, Tiberius Software created the ANN models. Best models were identified by their Gini co-efficient, ability to predict the complication outcome selected, and their RMSE scores. The model ensemble for the complications recorded in the registry were determined, variables ranked and model accuracy recorded. Results show an effective model, able to predict to 85% of those likely to contract VAP and similar figures for those unlikely to contract VAP. This equates to 1 in 10 patients being missed, and 1 in 10 falsely being flagged for treatment. Important variables in model development are not related to physiological factors, but injury status and the treatment received (intubation and expected ICU stay more than 2 days). Application of a predictive model could reduce the number of false positives being treated in an ICU and identify those most at risk, thereby lowering treatment costs and potentially helping improve mortality rates.
Insights
An Artificial Neural Network model can predict Ventilator Associated Pneumonia (VAP) in trauma patients with 85% accuracy. This approach aims to reduce antibiotic resistance and ICU mortality by identifying at-risk patients earlier.
Area of Science:
- Critical Care Medicine
- Artificial Intelligence in Healthcare
- Trauma Surgery
Background:
- Ventilator Associated Pneumonia (VAP) is a significant cause of mortality in Intensive Care Unit (ICU) trauma patients.
- Current diagnostic methods (specimen culture) delay treatment, leading to broad-spectrum antibiotic overuse and antibiotic resistance.
- There is a critical need for early VAP risk prediction to optimize treatment and improve patient outcomes.
Purpose of the Study:
- To develop and validate an Artificial Neural Network (ANN) model for predicting VAP risk in intubated trauma patients.
- To assess the model's accuracy in identifying patients likely or unlikely to develop VAP.
- To explore the key variables influencing VAP development in this patient population.
Main Methods:
- Utilized the National Trauma Data Bank (V6.2) data files to create ANN models.
- Employed feed-forward/back propagation methodology for model development.
- Evaluated model performance using Gini coefficient, predictive accuracy for VAP outcome, and Root Mean Square Error (RMSE).
Main Results:
- The developed ANN model achieved approximately 85% accuracy in predicting both VAP likelihood and unlikelihood.
- The model identified injury status, intubation, and expected ICU stay >2 days as critical predictive variables.
- Approximately 1 in 10 patients were missed (false negative), and 1 in 10 were falsely flagged (false positive).
Conclusions:
- ANN models offer a promising tool for predicting VAP risk in trauma patients.
- Early identification of high-risk patients can reduce unnecessary antibiotic use, potentially lowering treatment costs and improving mortality rates.
- Predictive modeling shifts focus from physiological factors to injury and treatment variables for VAP risk assessment.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:30Pneumonia III: Complications and Assessment
01:29Mechanical Ventilation I: Indication and Settings
01:22Cardiopulmonary Resuscitation II: ACLS Airway Management